Name | Indeloxazine hydrochloride |
Synonyms | Elen Noin CI 874 YM 08054 YM 08054-1 Indeloxazine hydrochloride (±)-2-[(7-Indenyloxy)methyl]morpholine Hydrochloride (±)-2-[(1H-Inden-7-yloxy)methyl]morpholine Hydrochloride MORPHOLINE, 2-[(1H-INDEN-7-YLOXY)METHYL]-, HYDROCHLORIDE (±)-2-[(1H-Inden-7-yloxy)methyl]morpholine hydrochloride Morpholine, 2-[(1H-inden-7-yloxy)methyl]-, hydrochloride, (R)- |
CAS | 65043-22-3 104908-43-2 |
InChI | InChI=1/C14H17NO2.ClH/c1-3-11-4-2-6-14(13(11)5-1)17-10-12-9-15-7-8-16-12;/h1-4,6,12,15H,5,7-10H2;1H |
Molecular Formula | C14H18ClNO2 |
Molar Mass | 267.75 |
Melting Point | 169-170°; mp 155-156° |
Boling Point | 401.4°C at 760 mmHg |
Flash Point | 160.3°C |
Vapor Presure | 1.18E-06mmHg at 25°C |
Storage Condition | Sealed in dry,Room Temperature |
Physical and Chemical Properties | Polymorph compound: light yellow needles Crystal obtained from methanol, melting point 169-170 °c: colorless needle Crystal obtained from acetone, melting point 155-156 °c. Acute toxicity LD50 mice (mg/kg):47 intravenous. ()-configuration: crystals from ethanol, melting point 112-113 °c. [Α] D21 4.9 °(C = 5, methanol). (-)-configuration: crystals from isopropanol, melting point 142-142.5 °c. [Α] D20-4.9 °(C = 5, methanol). |
UN IDs | 3249 |
Hazard Class | 6.1(b) |
Packing Group | III |
Toxicity | LD50 in mice (mg/kg): 47 i.v. (Tachikawa) |